TipRanks
Go Ultimate55% OFF

Appili Therapeutics Inc Class A (APLIF) Revenue

Appili Therapeutics Inc Class A Revenue

Appili Therapeutics Inc Class A had a revenue of 117.89K in the quarter ending Jun 30, 2026, with 180.72%. This bring the company's revenue in the last twelve months to 378.81K, Increased 45.19%. In the fiscal year ending Mar 31, 2026, Appili Therapeutics Inc Class A had annual revenue of 244.18K with 143.10% growth.

Revenue (ttm)
378.81K
Revenue Growth
252.01%
P/S Ratio
1.94
Revenue/Employee
$34,883
Employees
7
Market Cap
$473.59K

Revenue Chart

Appili Therapeutics Inc Class A Revenue - Annual

0250K500K750K1M1.25M1.5M199.11K1.39M334.18K827.41K100.44K244.18K2017201820192020202120222023202420252026
Revenue History
Download to Excel
APLIF revenue history
Fiscal End DateRevenueChangeGrowth
Mar 31, 2026244.18K143.74K143.10%
Mar 31, 2025100.44K-726.96K-87.86%
Mar 31, 2024827.41K493.23K147.60%
Mar 31, 2023334.18K-1.06M-75.97%
Mar 31, 20221.39M1.39M―
Mar 31, 20210.00-199.11K-100.00%
Mar 31, 2020199.11K199.11K―
Jun 30, 20190.000.00―
Mar 31, 20180.000.00―
Mar 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
APLIF378.81K
TSE:KNE38.72K
TSE:MIR370.57K
TSE:VXL0.00
TSE:BIOV0.00